Data as of 3:29pm ET
| -0.25 / -9.09%|
The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 480.00, with a high estimate of 480.00 and a low estimate of 480.00. The median estimate represents a +19,100.00% increase from the last price of 2.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.